Difference between revisions of "Work Group SWOTs"

From HL7 TSC
Jump to navigation Jump to search
Line 11: Line 11:
 
*[http://www.hl7.org/library/committees/sigvi/CCOW_SWOT%20ANALYSIS.doc CCOW]
 
*[http://www.hl7.org/library/committees/sigvi/CCOW_SWOT%20ANALYSIS.doc CCOW]
 
*[http://www.hl7.org/Library/Committees/dss/Clinical%20Decision%20Support%20SWOT%2020090929.doc Clinical Decision Support]
 
*[http://www.hl7.org/Library/Committees/dss/Clinical%20Decision%20Support%20SWOT%2020090929.doc Clinical Decision Support]
*Clinical Genomics
+
*[http://www.hl7.org/Library/Committees/clingenomics/docs/CG%20SWOT%2020100519_FINAL.doc Clinical Genomics]
 
*[http://www.hl7.org/documentcenter/public/wg/cic/CIC%20SWOT%20Analysis_updt_Dec%202009.doc Clinical Interoperability Council]
 
*[http://www.hl7.org/documentcenter/public/wg/cic/CIC%20SWOT%20Analysis_updt_Dec%202009.doc Clinical Interoperability Council]
 
*[http://www.hl7.org/library/committees/clinicalstatements/Clinical_Statement_SWOT%20200909.doc Clinical Statement]
 
*[http://www.hl7.org/library/committees/clinicalstatements/Clinical_Statement_SWOT%20200909.doc Clinical Statement]

Revision as of 18:22, 20 May 2010

Work Group Strengths, Weaknesses, Opportunities, and Threats (SWOTs)

Why analyze SWOTs? See November 2008 Technical Newsletter (Headline bottom of page 7, content begins on page 8), here

Technical Steering Committee: TSC_SWOT

Steering Division SWOTs